Metformin protects the heart against chronic intermittent hypoxia through AMPK ‐dependent phosphorylation of HIF ‐1α

Résumé fourni par la source

Chronic intermittent hypoxia (IH), a major feature of obstructive sleep apnea syndrome (OSA), is associated with greater severity of myocardial infarction. In this study, we performed RNA sequencing of cardiac samples from mice exposed to IH, which reveals a specific transcriptomic signature of the disease, relative to mitochondrial remodeling and cell death. Corresponding to its activation under chronic IH, we stabilized the Hypoxia Inducible Factor‐1α (HIF‐1α) in cardiac cells in vitro and observed its association with an increased autophagic flux. In accordance, IH induced autophagy and mitophagy, which are decreased in HIF‐1α +/− mice compared to wild‐type animals, suggesting that HIF‐1 plays a significant role in IH‐induced mitochondrial remodeling. Next, we showed that the AMPK metabolic sensor, typically activated by mitochondrial stress, is inhibited after 3 weeks of IH in hearts. Therefore, we assessed the effect of metformin, an anti‐diabetic drug and potent activator of AMPK, on myocardial response to ischemia–reperfusion (I/R) injury. Daily administration of metformin significantly decreases infarct size without any systemic beneficial effect on insulin resistance under IH conditions. The cardioprotective effect of metformin was lost in AMPKα2 knock‐out mice, demonstrating that AMPKα2 isoform promotes metformin‐induced cardioprotection in mice exposed to IH. Mechanistically, we found that metformin inhibits IH‐induced mitophagy in myocardium and decreases HIF‐1α nuclear expression in mice subjected to IH. In vitro experiments demonstrated that metformin induced HIF‐1α phosphorylation, decreased its nuclear localization, and HIF‐1 transcriptional activity. Collectively, these results identify the AMPKα2 metabolic sensor as a novel modulator of HIF‐1 activity. Our data suggest that metformin could be considered as a cardioprotective drug in OSA patients independently of their metabolic status.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.